This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
UK Index Housebuilders may be sensitive to Rightmove House Price data suggesting a rebound in September prices and a re-acceleration in annual growth.
Sirius Minerals - signed a 2.5 Mtpa POLY4 supply agreement with Cibra, Brazil’s 6th largest fertilizer distributor; takes 30% equity stake in Cibra in return for 95m Sirius shares. Closing price: 27.54p (Source: Company newswires)
Vodafone - incoming CEO is said to be mulling a sale of tens of thousands of masts to cut its €31bn debt pile. Closing price: 167.44p (Source: FT)
British American Tobacco - The US FDA suggests revisions to company's proposal to market Camel Snus as less harmful than cigarettes in US advertisements. Closing price: 3,659.5p (Source: DJ)
Boohoo.com - appoints John Lyttle as CEO (current Primark COO); Current joint CEO Kamani to become Chairman. Closing price: 170p (Source: Company newswires)
AstraZeneca - phase 3 Kronos trial of a three-drug combination for COPD treatment met eight out of its main objectives. Closing price: 167.44p (Source: FT)
(Sources: Company newswires, Bloomberg, CNBC, FT, Reuters, Wall Street Journal)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| ASTRAZENECA | AZN | -1.3% | -0.7% | -2.4% |
| JD SPORTS FASHION | JD/ | -4.1% | -2.4% | -4.6% |
| BHP BILLITON | BLT | 0.9% | 2.1% | 0.8% |
| RIO TINTO | RIO | 1.8% | 2.2% | 1.3% |
| ANGLO AMERICAN | AAL | 4.0% | 4.2% | 2.2% |
| GLENCORE | GLEN | 2.2% | 3.2% | 1.8% |
| VEDANTA RESOURCES | VED | -0.3% | 0.6% | -0.9% |
| BARRATT DEVELOPMENTS | BDEV | -0.1% | -0.1% | -2.1% |
| BERKELEY GROUP | BKG | 0.0% | 0.0% | -1.2% |
| PERSIMMON | PSN | 0.2% | 0.3% | -1.3% |
| BOVIS HOMES | BVS | 0.4% | 0.8% | -0.8% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.
Prepared by Michael van Dulken, Head of Research